Stereotactic radiosurgery services

UCLH is the home of the National Hospital for Neurology and Neurosurgery (NHNN) and a world-class radiotherapy centre, being a regional centre for sarcoma patients and the largest paediatric radiotherapy service in the UK. Neurosurgery and oncology are at the top of our priorities. The services include specialist clinicians, clinical nurse specialists and allied health professionals, who offer a comprehensive Neuro-oncology service covering the whole spectrum of brain and spinal tumours.

The Neuro-oncology MDT works across the NHNN, UCH Macmillan Cancer Centre and University College Hospital (UCH) and deals with both primary and secondary tumours of CNS in the adult and adolescent population. Patients with suspected or newly diagnosed tumours of the CNS are referred to the service through either neurology or neurosurgery at NHNN by general practitioners (GPs), accident and emergency departments or other acute medical services.

Patients may be seen as an outpatient or referred as an inpatient in emergency cases for assessment in our specialist brain tumour ward, the Molly Lane Fox (MLF) unit, or other inpatient wards at NHNN. Adolescent patients requiring assessment or inpatient treatment are transferred to the Children’s and Young People’s Cancer (CYPC) ward at the UCH.

UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients. UCLH provide the following services to the following areas:

• Neuro-oncology, skull base and pituitary tumours referrals are accepted from the North & North West London Neurosurgical Network
• Vascular and non-tumour includes & paediatric, referrals are accepted from the London, South & South West of England Paediatric Neuro-Oncology Networks
• Paediatric Neuro-oncology SRS/SRT, referrals are accepted from the London, South & South West of England Paediatric Neuro-Oncology Networks

We are an established provider of high-quality SRS/SRT treatment with a strong focus on the patient experience, with the skills and capacity to treat the full range of indications. A collaborative and expansive research programme has been implemented drawing on the combined expertise, from NHNN, UCL, the Macmillan Cancer Centre and in conjunction with other providers and international collaborators.